Topical antivirals

Definition and Pharmacological Role

Topical antivirals are a subclass of antiviral medications that are administered directly to the skin or mucous membranes for the treatment of localized viral infections, particularly those caused by Herpesviridae, such as Herpes simplex virus (HSV-1 and HSV-2) and Varicella-zoster virus (VZV). These formulations are designed to target viral replication at the site of lesion, reducing viral shedding, lesion duration, pain, and symptom severity without causing systemic effects.

They are most commonly used to manage:

• Herpes labialis (cold sores)

• Genital herpes

• Herpetic keratitis (eye infections)

• Herpes zoster (shingles, adjunct topical use)

• Molluscum contagiosum (in select pediatric cases)

• Human papillomavirus (topical immunomodulation)

• Minor viral dermatoses

---

Mechanism of Action

Topical antiviral agents primarily act by inhibiting viral DNA replication or interfering with viral protein synthesis. The specific mechanisms include:

1. Nucleoside analogues (e.g., acyclovir, penciclovir):

   • Require intracellular phosphorylation by viral thymidine kinase (TK)

   • Inhibit viral DNA polymerase

   • Terminate viral DNA chain elongation

2. Immunomodulators (e.g., imiquimod):

   • Stimulate local cytokine production, particularly interferon-alpha

   • Activate immune cells to attack virus-infected keratinocytes

3. Physical agents (e.g., hydrogen peroxide or nitric oxide donors):

   • Disrupt viral capsids or induce oxidative damage to viral components

---

Generic Names of Common Topical Antivirals

1. Acyclovir (Topical)

   • Antiviral nucleoside analogue

   • Used for herpes labialis and genital herpes

   • Decreases lesion healing time and viral shedding

   • Brand examples: Zovirax® cream, ointment (5%)

2. Penciclovir (Topical)

   • Similar to acyclovir, with longer intracellular half-life

   • Used for cold sores (herpes labialis)

   • More effective if applied early during prodrome

   • Brand: Denavir® (1% cream)

3. Docosanol

   • Long-chain aliphatic alcohol

   • Fusion inhibitor: blocks viral entry into host cells

   • Available OTC for cold sores

   • Must be applied within 12 hours of symptom onset

   • Brand: Abreva® (10% cream)

4. Imiquimod

   • Immune response modifier (not a direct antiviral)

   • Induces cytokines: IFN-α, IL-12, TNF-α

   • Used for:

     • External genital/perianal warts (HPV)

     • Molluscum contagiosum (off-label)

     • Actinic keratosis

     • Superficial basal cell carcinoma

   • Brands: Aldara® (5% cream), Zyclara® (2.5%, 3.75% creams)

5. Trifluridine (Ophthalmic Only)

   • Fluorinated pyrimidine nucleoside

   • Used for herpetic keratitis (HSV-1 and HSV-2)

   • Applied as an ophthalmic solution

   • Brand: Viroptic® (1% solution)

6. Ganciclovir (Ophthalmic Gel)

   • Nucleoside analogue, selectively inhibits CMV and HSV DNA polymerase

   • Used for acute herpetic keratitis

   • Brand: Zirgan® (0.15% gel)

7. Nitric Oxide-Based Compounds (Investigational/Topical Use)

   • Demonstrated antiviral activity against HSV-1

   • Cause oxidative stress to viral envelope and genome

8. Hydrogen Peroxide 1% Cream (Topical)

   • Non-specific antiviral activity

   • Approved in some regions (e.g., EU) for herpes labialis

9. Podophyllotoxin (Keratolytic/Viral Protein Inhibitor)

   • Used for anogenital warts caused by HPV

   • Inhibits viral replication and mitosis in infected epithelial cells

   • Brand: Condyline® (0.5% solution), Wartec® (cream)

---

Therapeutic Indications

Condition	Topical Antiviral Used
Herpes labialis (cold sores)	Acyclovir, Penciclovir, Docosanol, Hydrogen Peroxide
Genital herpes (adjunct therapy)	Acyclovir, Imiquimod
Herpetic keratitis (ocular HSV)	Trifluridine, Ganciclovir
Genital warts (HPV-related)	Imiquimod, Podophyllotoxin
Molluscum contagiosum (off-label)	Imiquimod
Herpes zoster (shingles, supportive)	Topical acyclovir (limited efficacy)

Formulations and Route of Administration

Topical antivirals are available in various dermal or mucosal formulations:

• Creams: e.g., acyclovir, penciclovir, docosanol, imiquimod

• Ointments: e.g., acyclovir (for mucocutaneous herpes)

• Solutions: e.g., podophyllotoxin, trifluridine

• Gels: e.g., ganciclovir ophthalmic

• Pads or pre-soaked swabs: e.g., genital wart treatments

• Ophthalmic drops: for ocular herpes (Rx only)

---

Adverse Effects

Topical antivirals are generally well-tolerated, though local reactions are common:

1. Application site reactions:

   • Burning, stinging, erythema, drying, pruritus

2. Contact dermatitis:

   • Particularly with imiquimod, docosanol

3. Hypopigmentation or erythema:

   • With prolonged use of imiquimod or podophyllotoxin

4. Ocular irritation:

   • With trifluridine and ganciclovir eye formulations

5. Flu-like symptoms (rare, imiquimod):

   • Fever, fatigue, lymphadenopathy due to immune activation

---

Contraindications

• Hypersensitivity to active ingredients (e.g., acyclovir, docosanol)

• Broken skin or open wounds (unless approved for such use)

• Avoid ocular application unless product is ophthalmic-specific

• Pregnancy/lactation (specific agents require risk-benefit assessment)

---

Drug Interactions

Topical antivirals generally have minimal systemic absorption, thus limited drug-drug interactions. However:

• Imiquimod: avoid co-application with immunosuppressive or corticosteroid creams (antagonistic effects)

• Podophyllotoxin: additive irritant effects with other keratolytics

• Avoid mixing antiviral creams with barrier ointments (can reduce absorption)

---

Use in Special Populations

• Pediatrics:

  • Acyclovir approved for infants with mucocutaneous HSV

  • Imiquimod: off-label for molluscum in children over 2 years

• Pregnancy:

  • Acyclovir topical: generally considered safe

  • Imiquimod: use only if clearly indicated (Category C)

• Immunocompromised:

  • May need systemic therapy; topical agents used adjunctively

---

Patient Counseling Points

• Apply at first sign of prodromal symptoms (tingling, itching)

• Wash hands before and after application

• Avoid sharing personal items (lip balm, towels)

• Use glove or cotton applicator to reduce virus spread

• For ocular antivirals: do not use contact lenses during treatment

• Continue full treatment course, even if lesions begin healing early

• Inform patients that topical antivirals do not prevent transmission of herpes

---

Examples of Brand Formulations

Brand Name	Generic Name	Formulation	Indication
Zovirax®	Acyclovir	5% cream/ointment	Herpes labialis, genital HSV
Denavir®	Penciclovir	1% cream	Cold sores
Abreva®	Docosanol	10% cream (OTC)	Cold sores
Aldara®	Imiquimod	5% cream	Genital warts, AKs, BCC
Zyclara®	Imiquimod	2.5%, 3.75% creams	Genital warts, AKs
Condyline®	Podophyllotoxin	0.5% solution	Genital warts (HPV)
Viroptic®	Trifluridine	1% ophthalmic solution	Herpetic keratitis
Zirgan®	Ganciclovir	0.15% ophthalmic gel	Ocular HSV

Clinical Guidelines

• CDC (Centers for Disease Control and Prevention):

  • Recommends topical antivirals for herpes labialis and external genital herpes only in specific circumstances; systemic therapy preferred for recurrent genital HSV

• American Academy of Dermatology (AAD):

  • Supports topical antiviral use in early-stage cold sores; supports imiquimod for HPV-related lesions

• AAO (American Academy of Ophthalmology):

• Ophthalmic antivirals are first-line for HSV keratitis, with trifluridine and ganciclovir being preferred topical agents